Professional Documents
Culture Documents
Case Title:: Vaagdevi Pharmacy College
Case Title:: Vaagdevi Pharmacy College
Case Title:: Vaagdevi Pharmacy College
By :
SAI CHARAN
20ED1T0014
INTRODUCTION:
RA is the most common form of autoimmune arthritis, About 75 percentage of RA Patients are women.
The disease most often begins between the ages of 30 and 50.However RA can occur at any age
RA is a chronic disease that causes joint pain, stiffness, swelling and decreased movement of the joints.
Small joints in the hands and feet are most commonly affected. Sometimes RA can affect other organs, such
as eyes, skin or lungs
The joint stiffness in RA is often worst in morning .it may last one to two hours .
stiffness for a long time in the morning is a clue that you may have RA .as this is not common
in other conditions like for a instance, osteoarthritis ,arthritis ,SLE’s etc.
Other signs and symptoms that can occur in RA include:
Low grade fevers
Anorexia
Fatigue
loss of appetite
firm lumps called rheumatoid nodules, which grow beneath the skin in places such as elbow and hands
DEFINATION :
Epidemiology :
LUNGS :
Inflammtion of pleural cavity of lungs called pleuritis
BLOOD VESSELS :
Inflammation in blood vessels known as Vasculitis
OSTEOPOROSIS :
SPLENOMEGALY :
MALIGNANCIES LIKE :
Leukemia's
Lymphomas
Prostate and cervix cancer which rarely seen
PATHOPHYSIOLOGY:
ACTIVATION OF T LYMPHOCYTES
FORMATION OF PANNUS
ACTIVATION OF T LYMPHOCYTES :
RA triggers the Activation of T lymphocytes
releases the inflammatory mediators like macrophages, monocytes and cytokines which regulates
Increase in pro inf cytokines and decrease in anti inf cytokines ,imbalance leads to excessive inflammation
Activation of B lymphocytes
causes RA symptoms
FORMATION OF PANNUS :
Increase in INF cytokines causes imbalances between pro and anti inf cytokines
Cause RA symptoms
FERENTIAL DIAGNOSIS :
Patient may experience these RA symptoms associated with other conditions as :
Osteoarthritis
Psoriatic arthritis
Stensoing tenosynovitis
Polymyalgia Rheumatica
Fibromyalgia
Hypermobility syndrome
Paraneoplastic syndromes
GNOSTIC PARAMETERS :
LAB PARAMETERS :
CBC
ESR
CRP
RBS
Sr Creatinine
Spinal fluid analysis
RADIOGRAPHS :
X ray
MRI
Ultrasonography
IMMUNOLOGIC PARAMETERS :
Rheumatoid factor
Anti CCP (anti citriculated antibody)
ACPA (anti citriculated antibody )
MANAGEMENT :
Goals of treatment :
To reduce pain
To reserve joint function
To increase range of motion of joint (ROM)
• DMARDS
A Non biological DMARDS
B Biological DMARDS
CORTICOSTERIODS
NSAIDS
IMMUNOSUPRESSIVE AGENTS
IMMUNOSUPRESSIVE AGENTS :
1.T CYCLOSPORINE :
It is a immunomodulator or calcineurin inhibitor given at dose of 25-50mg once in a day per oral
MOA : IT is a calcineurin inhibitor , supress the T cell activation and differentiation (cause inflammation ) by inhibiting
synthesis of cytokines or inter leukins
INDICATION : RA , Psoriasis , bronchitis , organ rejections.
Adverse effects : tremors , HTN , nephrotoxicity , diarrhea
2.T AZATHIOPRINE :
It is a immunomodulator given at the dose of 50-75mg once a day per orally
MOA : it interferes with the cellular metabolism and inhibit the Dna and protien synthesis
INDICATION : RA , SLE’s , Crohn disease , ulcerative colitis
Adverse effects : leukopenia , lymphomas
DMARDS:
Non – Biological Dmards :
1.T METHOTREXATE :
It is called gold standard drug ,used in first line treatment of RA given per oral at dose of 7.5 – 10mg once in a day for a week .
MOA : it inhibits Dihydrofolic acid reductase which is responsible for the synthesis of Folic acid
helps in DNA synthesis
INDICATION :Rheumatoid arthritis , Psoriasis , myasthesia gravis , SLE’s , breast cancers
Adeverse effects :anemia,anorexia,nausea and vomit,renal failure ,leukopenia
4.SULFASALAZINE :
It is a immuno suppresive drug given per orally at the dose of 500mg twice a day
MOA : unkown moa but it has anti inflammatory properties which inhibits leukotriene synthesis ..
INDICATION : Rheumatoid arthritis , crohns diesase , ulcerative colitis
Adverse reactions : nausea vomiting , gastric distress , anorexia , headache
BIOLOGICAL DMARDS :
3.IL – 6 BLOCKERS :
Inj Tocilizumab
Dose : given 160mg SC once
Side effect : anaphlayctic reactions ,nausea
MOA : corticosteriods may inhibit the release of archadonic acid from the phospholipids therby reducing the formation of
prostaglandlin which cause inflammation
T Prednisolone : 5-7.5mg PO OD
Methyl prednisolone : 5mg PO OD
Beflazocort : 6-28mg PO OD
Triam citholone 40-120mg po OD
Adverse effects : edemas , pyscological effects like mood swings , confusions ,high blood pressure ,gastric problems
Non steroidal anti inflammatory drugs (NSAIDS) :
MOA : the main mechanism of action of nsaids are the inhibition of cyclooxygenase(COX) enzyme
Cox is required to convert archidonic acid into prostaglandlins which cause the inflammation
Drugs include
a) Ibuprofen : 400-800mg QID PO
b) Naproxen : 500 mg BD PO
c) Mefanamic acid : 500mg QID PO
d) Diclofenac sodium : 100mg OD PO
e) COXIBS LIKE
Celecoxib : 200mg BD PO
Etericoxib : 60-120mg OD PO
Etodolac : 300-600mg OD PO
CASE PROFILE :
SUBJECTIVE FINDINGS :
A 50 yrs male patient came to the hospital and admitted in rheumatology department
with chief complaints of joint pains and swelling in small joint fingers - since 6months
morning stiffness in joints and toes about 2hours and pain in lumbar region with difficulty in standing
PAST MEDICAL HISTORY :
No H/O DM /HTN/TB/CVA/CAD
FAMILY HISTORY :Nothing significant
Mixed diet
Non smoker , alcohol occassionaly and regular bowel habits ,no previous allergies
PHYSICAL EXAMINATION :
Patient is conscious and coherent
Diffused swelling present in all small inter-phalangeal and meta-carpophalangeal joints with redness of skin
GENERAL EXAMINATION :
Temp :Afebrile
BP :130/80mm hg
Pulse : 80bpm
SYSTEMIC EXSMINATION : CVS –s1 s2 + and P/A – soft
Provisional diagnosis : Polyarthritis
LAB FINDINGS :
1.CBC – Hb : 13.0 (13-17gm%)
2.Serum uric acid – 6.10 (3.4-7.0mg%)
3.Calcium -8.3 (8-10mg/dl)
4.CRP – 11.7mgm/l (0.0-6mgm/L)
5.RA Factor – 18.40IU/mL (<14Iu/mL )
6.ESR – 49 1st hour (0-9/1 st hour )
Corticosteriods :
/
Corticosteriods :
/
Corticosteriods :
/
Corticosteriods :
/
Corticosteriods :
/
Corticosteriods :
/
Corticosteriods :
/
Corticosteriods :
/
Corticosteriods :
/
OBJECTIVE FINDINGS :
DAY 1 DAY 2 DAY 3 DAY 4
CVS
IVF 1DNS - - iv ● ●
1RL
Inj.monocef Ceftriaxone 1g iv BID ● ● ● ●
Tab MVT - - po OD ● ●